Microstructural white matter abnormalities and remission of geriatric depression

Am J Psychiatry. 2008 Feb;165(2):238-44. doi: 10.1176/appi.ajp.2007.07050744. Epub 2008 Jan 2.

Abstract

Objective: White matter abnormalities may interfere with limbic cortical balance and lead to chronic depressive syndromes. The authors used diffusion tensor imaging to test the hypothesis that depressed elders who fail to achieve remission have microstructural white matter abnormalities in cortico-striato-limbic networks implicated in geriatric depression.

Method: The subjects were nondemented individuals with nonpsychotic major depression. After a 2-week placebo period, those subjects who had a Hamilton Depression Rating Scale (HAM-D) score of 18 or greater received escitalopram, 10 mg daily, for 12 weeks. Remission was defined as a HAM-D score of 7 or below for 2 consecutive weeks. Diffusion tensor imaging was performed at a 1.5 Tesla scanner, and voxel-based analysis of fractional anisotropy was conducted using age as the covariate.

Results: Subjects who failed to achieve remission (N=23) had lower fractional anisotropy in multiple frontal limbic brain areas, including the rostral and dorsal anterior cingulate, dorsolateral prefrontal cortex, genu of the corpus callosum, white matter adjacent to the hippocampus, multiple posterior cingulate cortex regions, and insular white matter, relative to those who achieved remission (N=25). In addition, lower fractional anisotropy was detected in the neostriatum and midbrain as well as select temporal and parietal regions.

Conclusions: Lower fractional anisotropy in distributed cerebral networks is associated with poor antidepressant response of geriatric depression and may represent a neuroanatomical substrate that predisposes to this disorder.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Anisotropy
  • Brain / metabolism
  • Brain / pathology*
  • Brain / ultrastructure*
  • Citalopram / therapeutic use*
  • Cognition Disorders / drug therapy
  • Cognition Disorders / pathology
  • Cognition Disorders / psychology
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / pathology*
  • Diffusion Magnetic Resonance Imaging / statistics & numerical data*
  • Frontal Lobe / metabolism
  • Frontal Lobe / pathology
  • Frontal Lobe / ultrastructure
  • Geriatric Assessment
  • Humans
  • Image Processing, Computer-Assisted
  • Limbic System / metabolism
  • Limbic System / pathology
  • Limbic System / ultrastructure
  • Middle Aged
  • Neural Pathways / metabolism
  • Neural Pathways / pathology
  • Neural Pathways / ultrastructure
  • Placebos
  • Psychiatric Status Rating Scales / statistics & numerical data
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Placebos
  • Serotonin Uptake Inhibitors
  • Citalopram